Fine-Scale Mapping of the FGFR2 Breast Cancer Risk Locus: Putative Functional Variants Differentially Bind FOXA1 and E2F1
Kerstin B. Meyer(Siriraj Hospital), José Ignacio Arias(Spanish National Cancer Research Centre), Nichola Johnson(Institute of Cancer Research), Marjanka K. Schmidt(University of Cambridge), Laura van ‘t Veer, Peter A. Fasching(Universitätsklinikum Erlangen), Helen Tsimiklis(The University of Melbourne), Michael J. Kerin(Ollscoil na Gaillimhe – University of Galway), Thérèse Truong(Université Paris-Sud), Annegien Broeks, Pornthep Siriwanarangsan(Ministry of Public Health), Joe Dennis(University of Cambridge), Kenneth Muir(Manchester Academic Health Science Centre), F Marmé(Heidelberg University), F. Ménégaux(Université Paris-Sud), Sarah Stewart‐Brown(University of Warwick), Pascal Guénel(Inserm), Ian Tomlinson(University of Oxford), Roger L. Milne(The University of Melbourne), Arif B. Ekici(University Medical Center Groningen), Kyriaki Michailidou(Cyprus Institute of Neurology and Genetics), Radhika Prathalingham(University of Cambridge), Juliet D. French(The University of Queensland), Michael P. Lux(Brüderkrankenhaus St. Josef Paderborn), Elinor J. Sawyer(King's College London), Olivia Fletcher(Breast Cancer Care), Saskia Carlebur(University of Cambridge), Stig E. Bojesen(University of Copenhagen), Inês de Santiago(MRC London Institute of Medical Sciences), M. Pilar Zamora(Universidad Autónoma de Madrid), Børge G. Nordestgaard(Gentofte Hospital), Stacey L. Edwards(Queensland University of Technology), Christof Sohn, Andreas Schneeweiß(German Cancer Research Center), Melissa C. Southey(The University of Melbourne), Pierre Laurent‐Puig(Inserm), Qin Wang(University of Cambridge), Barbara Burwinkel(German Cancer Research Center), Matthias W. Beckmann, Frans B.L. Hogervorst(The Netherlands Cancer Institute), John L. Hopper(The University of Melbourne), Artitaya Lophatananon(University of Warwick), Sune F. Nielsen(Herlev Hospital), Carmel Apicella(The University of Melbourne), Julian Peto(University of Helsinki), Henrik Flyger(Herlev Hospital), Manjeet K. Bolla(University of Cambridge), Isabel dos‐Santos‐Silva(London School of Hygiene & Tropical Medicine), Nicola Miller(Ollscoil na Gaillimhe – University of Galway), Martin O’Reilly(Cancer Research UK)
Cited by 117
Related Papers
A Gene-Expression Signature as a Predictor of Survival in Breast Cancer
|New England Journal of Medicine|2002|6.5k
The consensus molecular subtypes of colorectal cancer
|Nature Medicine|2015|5.3k
Pathological complete response and long-term clinical benefit in breast cancer: the CTNeoBC pooled analysis
|The Lancet|2014|4.7k
Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel
|European Heart Journal|2017|3.8k
Average Risks of Breast and Ovarian Cancer Associated with BRCA1 or BRCA2 Mutations Detected in Case Series Unselected for Family History: A Combined Analysis of 22 Studies
|The American Journal of Human Genetics|2003|3.7k